The Impact of Clinical Pharmacy Services on Direct Oral Anticoagulant Medication Selection and Dosing in the Ambulatory Care Setting
Journal of Pharmacy Practice · 2024
DOI: 10.1177/08971900231166555 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy Practice, 2024. Verfasst von Naomi Y Yates und 2 weiteren Autor:innen. Beteiligte Einrichtung: Manager, Clinical Pharmacy Services, Kaiser Permanente, Tucker, GA, USA. Hauptthemen laut MEDLINE: Anticoagulants, Ambulatory Care, Pharmacists, Pharmacy Service, Hospital. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Background
Off-label dosing of direct oral anticoagulants (DOACs) is both common and associated with adverse patient outcomes. Evidence describing best practices to support optimal direct oral anticoagulant (DOAC) dosing is limited.
Objective
To describe the impact of clinical pharmacist intervention on DOAC prescribing.
Methods
This retrospective study was a descriptive analysis conducted within an integrated healthcare system with a centralized, pharmacist-led Anticoagulation Management Service (AMS). Patients prescribed a DOAC between January 1, 2020 and December 31, 2020 were included. Pharmacy dispensing reports were generated for pharmacist review and anticoagulant drug therapy changes were recommended to physicians where appropriate. The primary objective was to describe the number and type of recommendations made. Secondary objectives were to determine the provider acceptance rate based on the intervention type and on clinical vs formulary recommendations.
Results
Clinical pharmacists made 147 recommendations for 2331 unique patients included in the analysis. Twenty-three recommendations (16%) were to decrease the dose, 46 (31%) were to increase the dose, 14 (10%) were to change the medication due to clinical scenario, 62 (42%) were to change the medication due to cost, and 2 (1%) were another issue. One hundred twenty-three (84%) recommendations were accepted. The provider acceptance rate was similar for clinical and formulary recommendations (85% and 82% respectively).
Conclusion
Implementation of report-driven clinical pharmacist intervention led to an improvement in appropriate DOAC medication selection and dosing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Manager, Clinical Pharmacy Services, Kaiser Permanente, Tucker, GA, USA.
- Ambulatory Care Clinical Pharmacy Specialist, Kaiser Permanente, Duluth, GA, USA.
- Manager, Clinical Pharmacy Cardiovascular Services, Kaiser Permanente, Aurora, CO, USA.
ORCID-Profile: Naomi Y Yates
Zitieren
APA
Yates, N. Y., Hale, S. A., & Clark, N. P. (2024). The Impact of Clinical Pharmacy Services on Direct Oral Anticoagulant Medication Selection and Dosing in the Ambulatory Care Setting. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900231166555
Vancouver
Yates NY, Hale SA, Clark NP. The Impact of Clinical Pharmacy Services on Direct Oral Anticoagulant Medication Selection and Dosing in the Ambulatory Care Setting. Journal of Pharmacy Practice. 2024. doi:10.1177/08971900231166555
BibTeX
@article{Yates2024,
author = {Yates, Naomi Y and Hale, Stephanie A and Clark, Nathan P},
title = {The Impact of Clinical Pharmacy Services on Direct Oral Anticoagulant Medication Selection and Dosing in the Ambulatory Care Setting},
journal = {Journal of Pharmacy Practice},
year = {2024},
doi = {10.1177/08971900231166555}
}
EUVIMED